Myeloid-derived suppressor cells—new and exciting players in lung cancer
2020 · Journal of Hematology & Oncology · 191 citations
https://doi.org/10.1186/s13045-020-0843-1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
260
Citations
4
h-index
4
i10-index
Lanling Weng is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Immune cells in cancer & Metal-Organic Frameworks: Synthesis and Applications. The author has an h-index of 4, co-authored 5 publications.
https://doi.org/10.1186/s13045-020-0843-1
https://doi.org/10.1016/j.biopha.2020.110740
Click to start Chat